1. Home
  2. FORTY vs ANIP Comparison

FORTY vs ANIP Comparison

Compare FORTY & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORTY
  • ANIP
  • Stock Information
  • Founded
  • FORTY 1985
  • ANIP 2001
  • Country
  • FORTY Israel
  • ANIP United States
  • Employees
  • FORTY N/A
  • ANIP N/A
  • Industry
  • FORTY EDP Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORTY Technology
  • ANIP Health Care
  • Exchange
  • FORTY Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • FORTY 2.3B
  • ANIP 2.0B
  • IPO Year
  • FORTY 1997
  • ANIP N/A
  • Fundamental
  • Price
  • FORTY $148.00
  • ANIP $93.29
  • Analyst Decision
  • FORTY
  • ANIP Strong Buy
  • Analyst Count
  • FORTY 0
  • ANIP 7
  • Target Price
  • FORTY N/A
  • ANIP $99.14
  • AVG Volume (30 Days)
  • FORTY 367.0
  • ANIP 343.4K
  • Earning Date
  • FORTY 11-20-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • FORTY 0.96%
  • ANIP N/A
  • EPS Growth
  • FORTY 15.06
  • ANIP N/A
  • EPS
  • FORTY 4.97
  • ANIP N/A
  • Revenue
  • FORTY $2,889,481,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • FORTY N/A
  • ANIP $39.99
  • Revenue Next Year
  • FORTY N/A
  • ANIP $9.57
  • P/E Ratio
  • FORTY $28.18
  • ANIP N/A
  • Revenue Growth
  • FORTY 8.58
  • ANIP 38.68
  • 52 Week Low
  • FORTY $77.50
  • ANIP $52.50
  • 52 Week High
  • FORTY $151.31
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • FORTY 64.71
  • ANIP 52.75
  • Support Level
  • FORTY $142.00
  • ANIP $93.00
  • Resistance Level
  • FORTY $151.31
  • ANIP $96.99
  • Average True Range (ATR)
  • FORTY 0.95
  • ANIP 2.81
  • MACD
  • FORTY 0.52
  • ANIP 0.14
  • Stochastic Oscillator
  • FORTY 83.52
  • ANIP 60.60

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources, Michpal, ZAP Group, and Others. The majority of the company's revenue comes from Israel.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: